High-risk human papillomavirus genotyping in cervical cancers in Tanzania
We found a high proportion of hrHPV among cervical carcinomas diagnosed in Tanzania. Rolling out HPV vaccines that target more hrHPV types than HPV16/18, especially HPV35 and HPV45, could optimize protection against cervical cancer in Tanzania.
Authors
- Eulade Rugengamanzi (ORCID: https://orcid.org/0000-0003-0385-3706)
- Atuganile Malango
- Asteria Kimambo
- Gallican Kubwimana
- Edda Vuhahula (ORCID: https://orcid.org/0000-0002-0023-972X)
- Kathryn Anastos
- Gad Murenzi (ORCID: https://orcid.org/0000-0002-5513-5522)
- Subira Matiku (ORCID: https://orcid.org/0009-0002-5509-0026)
- Philip E. Castle (ORCID: https://orcid.org/0000-0003-1082-6554)
- Obed Tuyishime
- Thomas Habanabakize
- Edwin Liwa (ORCID: https://orcid.org/0000-0001-5664-9915)
Institutions
- National Institutes of Health (US)
- Albert Einstein College of Medicine (US)
- Muhimbili University of Health and Allied Sciences (TZ)
- Catholic University of Health and Allied Sciences (TZ)
- Rwanda Development Board (RW)
- Kilimanjaro Christian Medical Centre (TZ)
- Muhimbili National Hospital (TZ)
- National Cancer Institute (US)
Publication Details
- Journal
- Infectious Agents and Cancer
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1186/s13027-024-00596-1
- Citations
- 5
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Muhimbili University of Health and Allied Sciences
- University of Health and Allied Sciences